Gamifant (emapalumab-lzsg) / SOBI  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gamifant (emapalumab-lzsg) / SOBI
NCT01459562: First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers

Completed
1
20
Europe
NI-0501, Placebo
Swedish Orphan Biovitrum
Healthy Volunteers
01/13
01/13
NCT04765553: A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.

Completed
1
8
Japan
NI-0501, Gamifant, Saline, Placebo
Swedish Orphan Biovitrum
Rare Diseases
06/21
07/21
NCT06439914: First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy

Not yet recruiting
1
6
US
[89Zr]Zr-DFO-emapalumab, Zirconium Zr 89-DFO-emapalumab
Nerissa T. Viola
Non Small Cell Lung Cancer
06/26
06/27
NCT06285825: A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

Not yet recruiting
1
32
US
Emapalumab
M.D. Anderson Cancer Center, Sobi, Inc.
Cytopenia
08/26
08/28

Download Options